Logo

VWR to Market Products, Services Made by Clinical Data’s Cogenics Business

Oct 31, 2006
NEW YORK (GenomeWeb News) — VWR will market products in Clinical Data’s Cogenics division, including its DNA sequencing services, to European companies and academic centers, Clinical Data said today.
 
Cogenics sells products and services once owned by Lark Technologies and Genome Express.
 
Financial terms of the deal were not released.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.